Editorial Commentary
Percutaneous ablation for renal masses
Annals of Translational Medicine
2019;
:1
(September 2019)
Percutaneous kidney ablation: a good option in selected cases
Annals of Translational Medicine
2019;
:2
(September 2019)
Improving biochemical markers for disorders of N-glycosylation
Annals of Translational Medicine
2019;
:3
(September 2019)
Clinical dilemmas in predicting the progression of pre-clinical hypertrophic cardiomyopathy—is MRI strain the solution?
Annals of Translational Medicine
2019;
:4
(September 2019)
Telemedicine for infectious disease care—how do we measure the true value?
Annals of Translational Medicine
2019;
:5
(September 2019)
Mesenchymal stromal cells for the treatment of osteoarthritis of knee joint: context and perspective
Annals of Translational Medicine
2019;
:6
(September 2019)
Stereotactic body radiotherapy for oligometastatic renal cell carcinoma—are we ready to roll?
Annals of Translational Medicine
2019;
:7
(September 2019)
Treatment of sepsis-induced acute kidney injury in the ICU: the therapeutic targets do not seem to be established yet
Annals of Translational Medicine
2019;
:8
(September 2019)
Safety and delayed intervention rates of active surveillance for small renal masses in an elderly population
Annals of Translational Medicine
2019;
:9
(September 2019)
The dark side of immunotherapy: challenges facing the new hope in cancer treatment
Annals of Translational Medicine
2019;
:10
(September 2019)
Precision surgery for obsessive compulsive disorder—which is the proper target?
Annals of Translational Medicine
2019;
:11
(September 2019)
Systemic therapy for metastatic renal cell carcinoma—is timing everything?
Annals of Translational Medicine
2019;
:12
(September 2019)
Nephrectomy in metastatic renal cell carcinoma with venous thrombus: more thrombus equals less benefit?
Annals of Translational Medicine
2019;
:13
(September 2019)
The importance of not only living longer but also better in the setting of advanced urothelial cancer
Annals of Translational Medicine
2019;
:14
(September 2019)
MRI-based radiosurgical planning: implications in imaging timing
Annals of Translational Medicine
2019;
:15
(September 2019)
Levodopa treatment in Parkinson’s disease: earlier or later?
Annals of Translational Medicine
2019;
:16
(September 2019)
The way towards tailored treatment for metastatic renal cancer patients in the omics era: are we getting a “transcriptomic compass”?
Annals of Translational Medicine
2019;
:17
(September 2019)
Is survival after sublobar resection vs. lobectomy made equivalent by extent of lymphadenectomy?
Annals of Translational Medicine
2019;
:18
(September 2019)
A call for a more rigorous screening of postoperative delirium
Annals of Translational Medicine
2019;
:19
(September 2019)
New functions assigned to a microRNA with genetic links to prostate cancer risk
Annals of Translational Medicine
2019;
:20
(September 2019)
Liquid biopsies in renal cell carcinoma with focus on epigenome analysis
Annals of Translational Medicine
2019;
:21
(September 2019)
Implications of the circular RNAs in localized prostate cancer
Annals of Translational Medicine
2019;
:22
(September 2019)
Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma and venous thrombus—trends and effect on overall survival
Annals of Translational Medicine
2019;
:23
(September 2019)
Whole genome sequencing in Mycobacterium tuberculosis
Annals of Translational Medicine
2019;
:24
(September 2019)
Bleeding in patients with atrial fibrillation treated with combined antiplatelet and anticoagulant therapy: time to turn the corner
Annals of Translational Medicine
2019;
:25
(September 2019)
Stereotactic ablative radiotherapy for early-stage central lung tumors: status, challenges, and future considerations
Annals of Translational Medicine
2019;
:26
(September 2019)
Suggestions for radiation oncologists to overcome radiotherapy interruption in patients with nasopharyngeal cancer
Annals of Translational Medicine
2019;
:27
(September 2019)
Prolonged albumin administration in patients with decompensated cirrhosis: the amount makes the difference
Annals of Translational Medicine
2019;
:28
(September 2019)
Advocate the implementation of video-assisted thoracoscopic surgery lobectomy program for early stage lung cancer treatment: time to transfer from why to how
Annals of Translational Medicine
2019;
:29
(September 2019)
Biomarkers in metastatic renal cell carcinoma in the era of immune checkpoint inhibitors
Annals of Translational Medicine
2019;
:30
(September 2019)
Testicular germ cell tumors: the changing role of the pathologist
Annals of Translational Medicine
2019;
:31
(September 2019)
The 8th UICC/AJCC TNM edition for non-small cell lung cancer staging: getting off to a flying start?
Annals of Translational Medicine
2019;
:32
(September 2019)
Apixaban or rivaroxaban in the treatment of acute venous thromboembolism?
Annals of Translational Medicine
2019;
:33
(September 2019)
Vitamin D deficiency and kidney hyperfiltration: a mechanism of kidney injury?
Annals of Translational Medicine
2019;
:34
(September 2019)
MGTX extension study longitudinally favors early thymectomy in non-thymomatous young-adult patients with AChR antibody-positive myasthenia gravis
Annals of Translational Medicine
2019;
:35
(September 2019)
GnRH agonist and letrozole in women with recurrent implantation failure
Annals of Translational Medicine
2019;
:36
(September 2019)
The importance of timing for the spontaneous breathing trial
Annals of Translational Medicine
2019;
:37
(September 2019)
Avoiding desaturation during endotracheal intubation: is high-flow nasal cannula the answer?
Annals of Translational Medicine
2019;
:38
(September 2019)
Five-year overall survival of pembrolizumab in advanced non-small cell lung cancer: another step from care to cure?
Annals of Translational Medicine
2019;
:39
(September 2019)
The use of nephrometry scoring systems can help urologists predict the risk of conversion to radical nephrectomy in patients scheduled for partial nephrectomy
Annals of Translational Medicine
2019;
:40
(September 2019)
Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): are neurologists feeling more comfortable to RESTART antiplatelet?
Annals of Translational Medicine
2019;
:41
(September 2019)
Are we facing a cure in lung cancer?—KEYNOTE-001 insights
Annals of Translational Medicine
2019;
:42
(September 2019)
Nutrition determines outcome after severe burns
Annals of Translational Medicine
2019;
:43
(September 2019)
Are nephrometry scores enough to select patients really fit for nephron sparing surgery?
Annals of Translational Medicine
2019;
:44
(September 2019)
Safety and efficacy of restarting antiplatelet therapy after intracerebral hemorrhage
Annals of Translational Medicine
2019;
:45
(September 2019)
Chlorthalidone vs. potassium citrate in a model of hypercalciuria: differential effects on stone and bone
Annals of Translational Medicine
2019;
:46
(September 2019)
Clinical glycomics in the diagnostic laboratory
Annals of Translational Medicine
2019;
:47
(September 2019)
Does impaired processing of pro-B-type (or brain) natriuretic peptide cause decreased plasma BNP levels in obese heart failure patients?
Annals of Translational Medicine
2019;
:48
(September 2019)
Immune-checkpoint inhibitors in brain metastases from renal cell carcinoma: a battle was lost but not the war
Annals of Translational Medicine
2019;
:49
(September 2019)
A simplified new-generation renal mass complexity scoring system
Annals of Translational Medicine
2019;
:50
(September 2019)
Efficacy and safety profiles of mechanical and pharmacological thromboprophylaxis
Annals of Translational Medicine
2019;
:51
(September 2019)
Integrating mass spectrometry-based plasma (or serum) protein N-glycan profiling into the clinical practice?
Annals of Translational Medicine
2019;
:52
(September 2019)
Expanding congenital abnormalities of the kidney and urinary tract (CAKUT) genetics: basonuclin 2 (BNC2) and lower urinary tract obstruction
Annals of Translational Medicine
2019;
:53
(September 2019)
Rapid and accurate diagnosis of hemoglobinopathy and β-thalassemia by ultrahigh-resolution mass spectrometry and tandem mass spectrometry from blood: review of a benchmark study
Annals of Translational Medicine
2019;
:54
(September 2019)
Prognostic relevance of tumor response after neoadjuvant therapy for patients with esophageal cancer
Annals of Translational Medicine
2019;
:55
(September 2019)
Cabozantinib in advanced non-clear-cell renal cell carcinoma: is it the way clearer now?
Annals of Translational Medicine
2019;
:56
(September 2019)
Neoadjuvant androgen deprivation therapy through intense inhibition of the androgen target: “Midsummer Night’s Dream” or “Much Ado About Nothing”?
Annals of Translational Medicine
2019;
:57
(September 2019)
Tumor location does not limit percutaneous treatment of small renal masses with microwave ablation
Annals of Translational Medicine
2019;
:58
(September 2019)
Is this the ultimate solution to fight erectile dysfunction post radical prostatectomy?
Annals of Translational Medicine
2019;
:59
(September 2019)
Time to talk about parents of ill children
Annals of Translational Medicine
2019;
:60
(September 2019)
Stereotactic ablative radiotherapy for operable stage I non-small cell lung cancer: not ready for prime time
Annals of Translational Medicine
2019;
:61
(September 2019)
VATS lobectomy for early lung cancer: long-term outcomes
Annals of Translational Medicine
2019;
:62
(September 2019)
Usefulness of the duration of acute kidney injury for predicting renal function recovery after partial nephrectomy
Annals of Translational Medicine
2019;
:63
(September 2019)
Managing intrinsic pro-degradatory mechanical and cellular cycles in the development of osteochondral lesions
Annals of Translational Medicine
2019;
:64
(September 2019)
Is twice better than once?—challenges of troponin measurements for risk prediction in the general population
Annals of Translational Medicine
2019;
:65
(September 2019)
Diagnosis of hemoglobinopathy and β-thalassemia by 21-Tesla Fourier transform ion cyclotron resonance mass spectrometry
Annals of Translational Medicine
2019;
:66
(September 2019)
GLP-1 analogue liraglutide as adjunct treatment in diabetes type 2 after failed bariatric/metabolic surgery
Annals of Translational Medicine
2019;
:67
(September 2019)
Acute kidney injury and long-term renal function after partial nephrectomy—is there a true association?
Annals of Translational Medicine
2019;
:68
(September 2019)
Role of lipoprotein (a) in peripheral arterial disease
Annals of Translational Medicine
2019;
:69
(September 2019)
Inflammatory proteins in diabetic kidney disease—potential as biomarkers and therapeutic targets
Annals of Translational Medicine
2019;
:70
(September 2019)
Disclosure:
The supplement was published without any sponsorship or funding.